The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity of Southern California
About this trial
The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.
Eligibility criteria
Qualifiers
degenerative lumbar disease
age of 18-75
undergoing open primary one- to three-level lumbar fusion
Disqualifiers
currently use a sleep aid nightly
diagnosed with insomnia or sleep apnea
history of delirium with opiates or zolpidem
allergic to opiates or zolpidem
Trial design
Treatments tested in this trial
- Zolpidem Tartrate 10 mg
- Placebo
Treatment groups
140 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov